ADVANCED PROSTATE CANCER
Clinical trials for ADVANCED PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED PROSTATE CANCER trials appear
Sign up with your email to follow new studies for ADVANCED PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for advanced prostate cancer: experimental drug GDC-1261 enters early trials
Disease control Not yet recruitingThis study tests a new drug called GDC-1261 in people with advanced or metastatic prostate cancer that has worsened despite prior treatment. The main goals are to check the drug's safety, find the best dose, and see if it can slow the cancer. About 260 participants will take part…
Matched conditions: ADVANCED PROSTATE CANCER
Phase: PHASE1, PHASE2 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated May 26, 2026 03:25 UTC
-
New hope for advanced prostate cancer: experimental drug cocktails enter human trials
Disease control Not yet recruitingThis study tests two experimental drugs (QLC5508 and QLH12016) alone or with standard hormone therapies in 212 men with advanced prostate cancer that has spread. The goal is to find safe doses and see if the combinations shrink tumors or lower PSA levels. Participants must have m…
Matched conditions: ADVANCED PROSTATE CANCER
Phase: PHASE1, PHASE2 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 03:22 UTC
-
New prostate cancer drug aims to block hormones and slow disease
Disease control Not yet recruitingThis study tests a new drug called teverelix DP in 40 men with advanced prostate cancer. The goal is to see if it can safely lower testosterone to castrate levels, which can help control the cancer. Participants receive injections on the first day and then every six weeks. The re…
Matched conditions: ADVANCED PROSTATE CANCER
Phase: PHASE2 • Sponsor: Antev Ltd. • Aim: Disease control
Last updated May 18, 2026 12:04 UTC